Edited by James V. Lavery, Christine Grady, Elizabeth R. Wahl and Ezekiel J. Emanuel
FOREWORD. Gerald T. Keusch, Boston University:
INTRODUCTION. James V. Lavery, St. Michael's Hospital and The University of Toronto; Elizabeth R. Wahl, Yale University Medical School; Christine Grady, Department of Clinical Bioethics, The Clinical Center, National Institutes of Health;
Ezekiel J. Emanuel, Department of Clinical Bioethics, The Clinical Center, National Institutes of Health:
SECTION I: COLLABORATIVE PARTNERSHIP.
Case 1. Community involvement in biodiversity prospecting in Mexico.
Case 2. Selling genes: consulting a genetic population database in
Tonga.
Case 3: Substantiality of a fluoride varnish feasability study in Nicaragua.
SECTION II: SCIENTIFIC VALIDITY.
Case 4: Malarone testing in pregnant women in Thailand.
Case 5: Neglected diseases: Incentives to Conduct Research in Developing Countries: the case of
Pharamomycin for visceral leishmaniasis in India.
SECTION III: SCIENTIFIC VALIDITY.
Case 7. The limitations of knowledge: equipsoise and a randomized treatment strategy for malaria in Ethiopia.
Case 8. Controversy surrounding the scientific value of the Vaxgen/Aventis (RV-144) Phase
III.
SECTION IV: FAIR SUBJECT AND COMMUNITY SELECTION.
Case 9. Pharmaceutical research in developing countries: testing a new sufracant in Bolivia.
Case 10: Trading Genes for Toothbrushes: Research with the Aka Pygmy people in the Central African Republic.
Case 11: Test Phase I
malaria vaccine: where should the research be conducted?.
SECTION V: FAVOURABLE RISK/BENEFIT ASSESSMENT.
Case 12: Ethical complcations during an investigation of malaria infection in native Amazonian populations in western Brazil.
Case 13: Access to treatment for trial participants
who become infected with HIV during the course of Phase I trials of a preventive HIV vaccine in South Africa.
SECTION VI: INDEPENDENT REVIEW.
Case 14: How independent is independent review? Partner notification in a study of sexually-transmitted diseases in Mpumalanga, South Africa.
Case 15: Which regulations protect subjects best: preventing HIV status disclosure in a community-based circumcision study in rural Uganda.
SECTION VII: INFORMED CONSENT.
Case 16: The challenge of informed consent in a genetic epidemiology study of noma in rural Nigeria.
Case 17:
Compensation to families who consent to research autopsy for their children in a study of malaria mortality in Malawi: respectful or coercive?.
SECTION VIII: RESPECT FOR ENROLLED SUBJECTS AND THEIR COMMUNITIES.
Case 18: A randomized trial of low-phytate corn for maternal-infant
micronutrient deficiency in Guatemala.
Case 19: Obligations to participants harmed in the course of the N-9 multi-centre vaginal microbicide trial in South Africa.
Case 20: Ethical challenges and controversy in a retrospective study of HIV-1 transmission in Uganda.
Case 21: Protecting
subjects in a study of domestic violence in South Africa: what services are researchers obligated to provide?.
APPENDIX I: ECONOMIC, SOCIAL, HEALTH AND DEVELOPMENT INDICATORS FOR THE CASE COUNTRIES.
There are no Instructor/Student Resources available at this time.
James V. Lavery is at St. Michael's Hospital and University of Toronto. Christine Grady is at the Department of Clinical Bioethics, The Clinical Center at the National Institutes of Health. Elizabeth R. Wahl is at Yale University Medical School.
There are no related titles available at this time.
Please check back for the special features of this book.